Novavax promises more vaccines to COVAX for low- and middle-income nations, bringing total commitment to 1.1B shots
As more and more Covid-19 vaccines hurtle toward emergency approvals, the call for equitable access across the globe has only grown. And Thursday afternoon, one company stepped up for the second time.
In a new non-binding agreement with COVAX, Novavax announced it has promised additional vaccine doses to the WHO’s distribution network for low- and middle-income countries, in conjunction with CEPI and Gavi. Novavax is working with the Serum Institute of India to deliver the doses, and its total commitment to COVAX — including binding purchase agreements and Thursday’s “memorandum of understanding” — now totals up to 1.1 billion shots.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 102,900+ biopharma pros reading Endpoints daily — and it's free.